相关实验视频
Updated: Jun 25, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
探索Janus激酶抑制剂用于白发症:一个全面的审查
Randa Bushwereb1, Gautam Srivastava2
1Faculty of Life Sciences and Education, University of South Wales, Pontypridd, UK.
Italian journal of dermatology and venereology
|May 23, 2024
概括
雅努斯激酶 (JAK) 抑制剂,如巴里西提尼布,在治疗脱发症方面表现出显著的疗效,改善了脱发症严重程度工具 (SALT) 的得分. 这些治疗方法耐受性很好,中度至重症病例的副作用大多是轻微的.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脱发症是慢性自身免疫性疾病,具有显著的心理社会影响.
- 简氏激酶 (JAK) 抑制剂已成为一个有前途的治疗途径.
- 了解它们的有效性对于患者管理至关重要.
研究的目的:
- 评估巴里西提尼布对影响头皮,眉毛和毛的白发症的疗效和安全性.
- 为了比较Ritlecitinib和Brepocitinib与Baricitinib的有效性.
- 为了提供JAK抑制剂在白发症治疗中的综合性审查.
主要方法:
- 从2015年开始在主要数据库中进行全面的电子文献搜索.
- 专注于对中度至重度脱发区的JAK抑制剂的临床研究.
- 评估脱发症严重程度工具 (SALT) 对疗效和不良事件对安全的评分.
主要成果:
- 与安慰剂相比,巴里西提尼布 (2mg和4mg) 在24周内显著降低了SALT得分.
- 巴里西提尼布,里特利西提尼布和布雷波西提尼布的疗效与安慰剂相似,巴里西提尼布4mg的边际优势.
- 所有的JAK抑制剂都耐受良好,主要是轻度和可控的不良事件.
结论:
- 雅克抑制剂,特别是巴里西提尼布,是适度至重度脱发症的有效治疗方法.
- 在SALT得分显著下降表明治疗的有效性.
- 安全性概况是有利的,主要是轻度和可管理的不良事件.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

